Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Luis Solís-Anaya"'
Autor:
Jorge Antonio Armenta-San Sebastián, César Hernández Guadarrama, Abraham Majluf-Cruz, Enrique Rico-Curiel, José Refugio Lopez-Gutiérrez, Teresa Arredondo-Garza, Gilberto Castañeda-Hernández, Ignacio Mariscal-Ramírez, Luis Solís-Anaya, Jorge Vela-Ojeda
Publikováno v:
Archives of Medical Research. 44:549-554
Background and Aims Rituximab is effective in the treatment of B-cell lymphoid malignances and some autoimmune diseases. Most patients receiving the first infusion of rituximab experience symptoms that decrease with subsequent infusions. It is assume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7352848252d8ce14a86c0d2d0ca633
https://doi.org/10.1016/j.arcmed.2013.09.011
https://doi.org/10.1016/j.arcmed.2013.09.011
Autor:
Oscar Perez, Monica Tejeda, Israel Saldivar, Alberto Artristian, Rosa María Arana-Trejo, Maria-Paula Hernández, Raquel Amador-Sánchez, Yolanda Lugo, Gregorio Ignacio, Juan-Carlos Solís-Poblano, Jorge Cruz-Rico, Luis Solís-Anaya
Publikováno v:
Blood. 128:5273-5273
The Ph chromosome is a translocation (9;22)(q34;q11), that results in the constitutive activation of the BCR/ABL tyrosine kinase. The incidence of BCR/ABL in Acute Lymphoblastic Leukemia (ALL) increases with age, from less than 5% in younger children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::336a6a43a18c0d73dda54748c58f0c39
https://doi.org/10.1182/blood.v128.22.5273.5273
https://doi.org/10.1182/blood.v128.22.5273.5273